100
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT

, , , , , , ORCID Icon, & show all
Pages 1955-1965 | Published online: 16 Nov 2021

References

  • Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308(8):788–795. doi:10.1001/jama.2012.962422910756
  • Selvarajah S, Kaur G, Haniff J, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol. 2014;176(1):211–218. doi:10.1016/j.ijcard.2014.07.06625070380
  • Jayachandran M, Qu S. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med Res Rev. 2021;41(1):616–629. doi:10.1002/med.2174233084092
  • Wang R, Song Y, Yan Y, et al. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis. Atherosclerosis. 2016;254:193–199. doi:10.1016/j.atherosclerosis.2016.10.00627755985
  • Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 2016;6(1):19520. doi:10.1038/srep1952026814153
  • Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150–163. doi:10.1016/j.cca.2018.05.04629803897
  • Wu AH, Gladden JD, Ahmed M, et al. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. 2016;213:4–7. doi:10.1016/j.ijcard.2015.08.11026341316
  • De Luca G, Secco GG, Santagostino M, et al. Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis. 2012;22(5):426–433. doi:10.1016/j.numecd.2010.08.00521186110
  • Cheong E, Ryu S, Lee JY, et al. Association between serum uric acid and cardiovascular mortality and all-cause mortality: a cohort study. J Hypertens. 2017;35(Suppl 1):S3–S9. doi:10.1097/HJH.000000000000133028350618
  • Kunadian V, Chieffo A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41(37):3504–3520. doi:10.1093/eurheartj/ehaa50332626906
  • Nudi F, Iskandrian AE, Schillaci O, et al. Diagnostic accuracy of myocardial perfusion imaging with CZT technology: systemic review and meta-analysis of comparison with invasive coronary angiography. JACC Cardiovasc Imaging. 2017;10(7):787–794. doi:10.1016/j.jcmg.2016.10.02328330657
  • Liu L, Abdu FA, Yin G, et al. Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA). J Nucl Cardiol. 2020;31(5):261–266. doi:10.1007/s12350-020-02252-8
  • Henzlova MJ, Duvall WL, Einstein AJ, et al. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606–639. doi:10.1007/s12350-015-0387-x26914678
  • Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42(6):831–837.11390544
  • Zhang C, Jiang L, Xu L, et al. Implications of hyperuricemia in severe coronary artery disease. Am J Cardiol. 2019;123(4):558–564. doi:10.1016/j.amjcard.2018.11.02730527777
  • Poldervaart JM, Reitsma JB, Backus BE, et al. Effect of using the HEART Score in patients with chest pain in the emergency department: a stepped-wedge, cluster randomized trial. Ann Intern Med. 2017;166(10):689–697. doi:10.7326/M16-160028437795
  • Li X, Meng X, Spiliopoulou A, et al. MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018;77(7):1039–1047. doi:10.1136/annrheumdis-2017-21253429437585
  • Pilemann-Lyberg S, Hansen TW, Tofte N, et al. Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes. Diabetes Care. 2019;42(6):1088–1094. doi:10.2337/dc18-217330885950
  • Savale L, Akagi S, Tu L, et al. Serum and pulmonary uric acid in pulmonary arterial hypertension. Eur Respir J. 2021;58(2):2000332. doi:10.1183/13993003.00332-202033446602
  • Ong G, Davis WA, Davis TM. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2010;53(7):1288–1294. doi:10.1007/s00125-010-1735-720349345
  • Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 2000;36:1072–1078.11116127
  • Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. doi:10.1136/bmj.j237628592419
  • Andrikou I, Tsioufis C, Dimitriadis K, et al. Uric acid as an independent predictor of coronary artery disease in essential hypertension: data from an 8-year-follow-up study. Clin Exp Pharmacol Physiol. 2018;45(8):866–869. doi:10.1111/1440-1681.1292829489034
  • Lazzeroni D, Bini M, Camaiora U, et al. Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery. Eur J Prev Cardiol. 2018;25(2):119–126. doi:10.1177/204748731774404529164926
  • Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54(2):273–284. doi:10.1373/clinchem.2007.09442518039719
  • Tscharre M, Herman R, Rohla M, et al. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173–179. doi:10.1016/j.atherosclerosis.2018.02.00329432935
  • Tseng WC, Chen YT, Ou SM, et al. U-shaped association between serum uric acid Levels with cardiovascular and all-cause mortality in the elderly: the role of malnourishment. J Am Heart Assoc. 2018;7(4). doi:10.1161/JAHA.117.007523.
  • Lai X, Yang L, Légaré S, et al. Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji cohort. Int J Cardiol. 2016;224:299–304. doi:10.1016/j.ijcard.2016.09.03527665401
  • Virdis A, Masi S, Casiglia E, et al. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years. Hypertension. 2020;75(2):302–308. doi:10.1161/HYPERTENSIONAHA.119.1364331813345
  • Fujihashi T, Sakata Y, Nochioka K, et al. Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART-2 study. ESC Heart Fail. 2021;8(2):1027–1038. doi:10.1002/ehf2.1276533377627
  • Daiber A, Hahad O, Andreadou I, et al. Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond. Redox Biol. 2021;42:101875. doi:10.1016/j.redox.2021.10187533541847
  • Maloberti A, Bossi I, Tassistro E, et al. Uric acid in chronic coronary syndromes: relationship with coronary artery disease severity and left ventricular diastolic parameter. Nutr Metab Cardiovasc Dis. 2021;31(5):1501–1508. doi:10.1016/j.numecd.2021.01.02333810962
  • Qin L, Yang Z, Gu H, et al. Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord. 2014;14(1):26. doi:10.1186/1471-2261-14-2624568132
  • Mazidi M, Katsiki N, Mikhailidis DP, et al. Associations of serum uric acid with total and cause-specific mortality: findings from individuals and pooling prospective studies. Atherosclerosis. 2020;296:49–58. doi:10.1016/j.atherosclerosis.2019.07.01932032905
  • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404–2410. doi:10.1001/jama.283.18.240410815083
  • Kamei K, Konta T, Ichikawa K, et al. Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20(6):904–909. doi:10.1007/s10157-016-1228-126779905
  • Winder M, Owczarek AJ, Mossakowska M, et al. Serum uric acid is a weak Independent predictor of overall survival in older adults. J Clin Med. 2021;10(19):4505. doi:10.3390/jcm1019450534640521